ClinicalTrials.gov
public full text
Public Domain
Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of perifosine in treating patients who have recurrent, refractory, locally advanced, or metastatic breast cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer#1096636
- Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma#1372624
- Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer#918336
- Doxorubicin in Treating Women With Advanced Breast Cancer#812769
- Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients#1057273
Record · ID 1230560
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive